Orexigen Announces Upcoming Presentations at XIII
Post# of 68
Posted On: 04/28/2016 9:35:08 AM
Orexigen Announces Upcoming Presentations at XIII -3-
34 minutes ago - DJNF
Securities and Exchange Commission on February 26, 2016 and its other reports, which are available from the SEC's website (www.sec.gov) and on Orexigen's website (www.orexigen.com) under the heading "Investors." All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
Contacts:
McDavid Stilwell
Corporate Communications and Business Development
Orexigen Therapeutics, Inc.
+1-858-875-8629
mstilwell@orexigen.com
Julie Normart
BrewLife (Media Contact for Orexigen)
+1-415-946-1087
jnormart@brewlife.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-announces-upcoming-presentations-at-xiii-international-congress-on-obesity-hosted-by-the-world-obesity-federation-300258949.html
SOURCE Orexigen Therapeutics, Inc.
/Web site: http://www.orexigen.com
(END) Dow Jones Newswires
34 minutes ago - DJNF
Securities and Exchange Commission on February 26, 2016 and its other reports, which are available from the SEC's website (www.sec.gov) and on Orexigen's website (www.orexigen.com) under the heading "Investors." All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
Contacts:
McDavid Stilwell
Corporate Communications and Business Development
Orexigen Therapeutics, Inc.
+1-858-875-8629
mstilwell@orexigen.com
Julie Normart
BrewLife (Media Contact for Orexigen)
+1-415-946-1087
jnormart@brewlife.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-announces-upcoming-presentations-at-xiii-international-congress-on-obesity-hosted-by-the-world-obesity-federation-300258949.html
SOURCE Orexigen Therapeutics, Inc.
/Web site: http://www.orexigen.com
(END) Dow Jones Newswires
(0)
(0)Orexigen Therapeutics (OREXQ) Stock Research Links
Scroll down for more posts ▼